What kind of company is KYBELLA?

Overview of KYBELLA

KYBELLA is a prescription medicine used for adults with moderate or severe submental fat , also known as a double chin. The active ingredient in KYBELLA is deoxycholic acid, which is a naturally occurring molecule in the body that aids in the breakdown and absorption of dietary fat. KYBELLA is manufactured by Allergan, a pharmaceutical company that produces a range of medical products, including Botox and Juvederm.

KYBELLA was approved by the U.S. Food and Drug Administration (FDA) in 2015 for the treatment of submental fat. Since then, the drug has become a popular and effective way to eliminate fat from under the chin without surgery. KYBELLA works by breaking down the fat cells under the chin, which are then naturally eliminated by the body.

History of KYBELLA

Allergan acquired KYBELLA from the pharmaceutical company Kythera Biopharmaceuticals in 2015 for $2.1 billion. Kythera had developed the drug and conducted phase III clinical trials before Allergan's acquisition. The FDA approved KYBELLA on April 29, 2015, making it the first and only non-surgical treatment for submental fullness.

How KYBELLA works

KYBELLA is administered via injections into the submental fat under the chin. The number of injections and the number of treatment sessions required varies depending on the patient's individual needs. The procedure takes around 20 to 30 minutes, and patients can typically return to their normal activities immediately afterward.

KYBELLA works by breaking down and destroying the fat cells in the treated area. Once destroyed, the fat cells can no longer store or accumulate fat. Over time, the body naturally eliminates the destroyed fat cells, leading to a noticeable reduction in submental fat.

KYBELLA side effects

Like any medical procedure, there are potential risks and side effects associated with KYBELLA injections. The most common side effects include swelling, bruising, pain, numbness, redness, and areas of hardness around the treatment site. These side effects are generally mild and subside on their own within a few days to a few weeks.

Conclusion

KYBELLA is an effective and safe treatment for submental fat, and it has gained widespread popularity since its approval by the FDA in 2015. Manufactured by Allergan, KYBELLA uses deoxycholic acid to break down and eliminate fat cells under the chin. It is a non-surgical alternative to procedures such as liposuction and chin implants. While there are potential side effects associated with treatment, most patients experience mild and temporary symptoms that resolve on their own.

Social media links